N/A
N=2,591
Project RESIST: Evaluating the Effects of Anti-smoking Inoculation Messages Among Young Adult Sexual Minority Women
Cigarette Smoking Behavior
Bottom Line
View on ClinicalTrials.gov: NCT05499520 ↗Enrolled (actual)
2,591
Serious AEs
0.0%
Results posted
Jul 2024
Primary outcome: Primary: Intention to Quit Smoking at Follow-up — 11.8; 11.0; 14.4; 9.9 units on a scale
Study Design & Population
- Study type
- Interventional
- Phase
- N/A
- Interventions
- Culturally Tailored Anti-Smoking Messages (Other)
- Age
- Adult · 18+ yrs
- Sex
- All
- Sponsor
- Abramson Cancer Center at Penn Medicine
- Primary completion
- Jul 2023
Outcome Measures
| Outcome | Result | p-value |
|---|---|---|
| PRIMARY Intention to Quit Smoking at Follow-up |
11.8; 11.0; 14.4; 9.9; 11.1; 14.4 | — |
| PRIMARY Intention to Purchase Cigarettes |
5.5; 5.7; 4.2; 5.9; 5.7; 3.9 | — |
| PRIMARY Susceptibility to Smoke Cigarettes |
3.0; 2.7; 2.2; 2.8; 2.5; 3.0 | — |
| SECONDARY Receptivity to Marketing |
6.3; 6.1; 6.4; 6.6; 6.8; 6.5 | — |
| SECONDARY Tobacco Industry Attitudes |
8.1; 8.2; 7.8; 7.6; 7.1; 7.4 | — |
| SECONDARY Tobacco Industry Beliefs |
11.7; 11.7; 10.9; 11.1; 10.4; 11.0 | — |
Summary
Project RESIST is an R01 study funded by NCI focused on determining the effects of using culturally tailored inoculation approaches to increase resilience to tobacco marketing influences among young adult sexual minority women ages 18-30 and incorporates critical stakeholder inputs that support later adoption and implementation. The study team is utilizing formative research to design and pre-test anti-smoking messages and two national longitudinal online survey experiments.
Eligibility Criteria
Inclusion Criteria
- Ages 18-30
- Woman
- Identifies as a sexual minority (any sexual orientation other than heterosexual)
- Lives in the United States
- Able to take surveys in English
Exclusion Criteria
- Under 18 or older than 30
- Men
- Heterosexual
- Lives outside the United States
- Unable to take the survey in English
Data sourced from ClinicalTrials.gov (NCT05499520). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication.